Kotak Flexi Cap Fund - Direct (G) vs Nippon India Pharma Fund - Direct (G)

Kotak Flexi Cap Fund - Direct (G) vs Nippon India Pharma Fund - Direct (G)

stock1

Kotak Flexi Cap Fund - Direct (G)

0.93%

stock2

Nippon India Pharma Fund - Direct (G)

7.4%

Loading chart...

About Fund

Deutsche Bank, AG Standard Chartered Bank

Computer Age Management Services (P) Ltd.

Deutsche Bank AG

Karvy Computershare Pvt. Ltd.

Very High Risk

100

55850.29

2.02

96.158

January 1, 2013

0

Very High Risk

5000

9044.23

1.12

634.5023

January 1, 2013

1

12.49 %

13.19 %

0.93 %

14.01 %

19.35 %

7.4 %

Harsha Upadhyaya

(B.E,Mechancial from Rec, suratkal. PGDM form IIM from Lucknow. CFA institute, USA.

Harsha began his career with Essar steel as an engineer and moved on to pursue higher studies. After completion of PGDM, he joined uti in 1996 and worked as an equity analyst tracking various sectors for over three years. Before his second stint with UTI Mutual Fund starting april 2006, harsha gained considerable experience on indian equity markets working as research analyst in local and foreign broking houses; he has also gained valuable experience in the areas of business analysis and finance working at Reliance Industries and Reliance energy.

Sailesh Raj Bhan

MBA (Finance), CFA.

Mr.Bhan is an MBA with specialization in Finance and CFA. Has over 9 Yrs. of experience in Equity Securities Research & Sequeir Investment Pvt. Ltd. for 5 years and with Emkay Share & stock Broker Pvt. Ltd. for 2 years.

Get your FAQs right